Rekovelle 72 mcg (Follitropin Delta SOLUTION) 72 MCG

REKOVELLE 72 MCG is a subcutaneous solution containing follitropin delta, used for fertility treatments. This medication supports ovulation in assisted reproductive techniques.

Strength

72 MCG

Manufacturer / TM Owner

FERRING INC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

REKOVELLE 72 MCG is primarily used in fertility treatments to stimulate ovulation. It is often part of assisted reproductive techniques, helping to regulate the menstrual cycle and support ovulation. This medication is used under medical supervision to address infertility issues related to ovulation.

Side Effects

Common effects of REKOVELLE 72 MCG may include mild injection site reactions, headaches, or abdominal discomfort. Some users may experience bloating or breast tenderness. These effects vary and are typically mild to moderate.

Precautions & Warnings

REKOVELLE 72 MCG should be used under medical supervision. It is important to follow the prescribed dosage and administration guidelines. Patients should inform their healthcare provider about any pre-existing conditions or allergies before starting this medication.

Avoid Interactions

REKOVELLE 72 MCG may interact with other medications, including those that affect hormone levels. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of this medication.

Frequently Asked Questions

REKOVELLE 72 MCG is used to stimulate ovulation in fertility treatments, often as part of assisted reproductive techniques.

REKOVELLE 72 MCG is administered subcutaneously, typically under medical supervision.

Common side effects may include injection site reactions, headaches, abdominal discomfort, bloating, or breast tenderness.

Potential interactions with other medications should be discussed with a healthcare provider to ensure safety and efficacy.

REKOVELLE 72 MCG should be used under medical supervision, and its suitability depends on individual health conditions and medical history.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.